| 今开：23.08 | 昨收：23.17 |
| 最高：23.58 | 最低：22.895 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：1.115035083E9 |
AtriCure(ATRC)02-02 05:05
$AtriCure(ATRC)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000914208-24-000053 Act: 34 Size: 18 KB 网页链接查看全文
AtriCure(ATRC)02-27 22:05
$AtriCure(ATRC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001323885-24-000022 Size: 6 KB 网页链接查看全文
AtriCure(ATRC)04-04 05:15
$AtriCure(ATRC)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001323885-24-000057 Act: 34 Size: 1 MB 网页链接查看全文
AtriCure(ATRC)03-07 20:35
$AtriCure(ATRC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001323885-24-000040 Size: 5 KB 网页链接查看全文
AtriCure(ATRC)03-06 05:45
$AtriCure(ATRC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001323885-24-000032 Size: 8 KB 网页链接查看全文
AtriCure(ATRC)03-06 05:55
$AtriCure(ATRC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001323885-24-000034 Size: 8 KB 网页链接查看全文
AtriCure(ATRC)02-17 03:15
$AtriCure(ATRC)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001323885-24-000016 Act: 34 Size: 10 MB 网页链接查看全文
AtriCure(ATRC)03-06 05:55
$AtriCure(ATRC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001323885-24-000035 Size: 6 KB 网页链接查看全文
AtriCure(ATRC)03-14 21:05
$AtriCure(ATRC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001323885-24-000042 Size: 4 KB 网页链接查看全文
AtriCure(ATRC)04-24 04:25
$AtriCure(ATRC)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-24-107036 Act: 34 Size: 22 KB 网页链接查看全文
2024年2月27日， AtriCure（ATRC）披露1笔公司内部人交易情况。董事WHITE ROBERT S.于2024年2月23日买入1.00万股。 【近期内部交易】 披露日期职位姓名交易日期买/卖数量每股成交价/美元总金额/美元2024年2月27日董事WHITE ROBERT S... 网页链接
同花顺（300033）金融研究中心10月14日讯，有投资者向百洋医药（301015）提问， 董秘您好，公司对医疗器械有涉猎吗？比如对电子耳蜗，无针注射器，可穿戴医疗器械等西方较为先进的医疗器械进行引进，品牌运营。 公司回答表示，投资者... 网页链接
$AtriCure(ATRC)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-24-107043 Act: 34 Size: 29 KB 网页链接
$AtriCure(ATRC)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-24-107036 Act: 34 Size: 22 KB 网页链接
$AtriCure(ATRC)$ DEF 14A Other definitive proxy statements Accession Number: 0001323885-24-000055 Act: 34 Size: 3 MB 网页链接
$AtriCure(ATRC)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001323885-24-000057 Act: 34 Size: 1 MB 网页链接
$AtriCure(ATRC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001323885-24-000053 Size: 4 KB 网页链接
$AtriCure(ATRC)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-002831 Act: 33 Size: 5 KB 网页链接
$AtriCure(ATRC)$ PRE 14A Other preliminary proxy statements Accession Number: 0001323885-24-000049 Act: 34 Size: 3 MB 网页链接
$AtriCure(ATRC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001323885-24-000046 Size: 4 KB 网页链接
$AtriCure(ATRC)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-002438 Act: 33 Size: 5 KB 网页链接
$AtriCure(ATRC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001323885-24-000044 Size: 6 KB 网页链接